Wuh-Liang Hwu1, Yin-Hsiu Chien2, Ni-Chung Lee2, Mei-Hsin Li2. 1. Department of Pediatrics and Medical Genetics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. hwuwlntu@ntu.edu.tw. 2. Department of Pediatrics and Medical Genetics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Abstract
OBJECTIVES: Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare inherited disorder of monoamine neurotransmitter synthesis; this deficiency leads to psychomotor delay, hypotonia, oculogyric crises, dystonia, and extraneurological symptoms. This study aimed to provide further insight into the clinical course of AADC deficiency in Taiwan. PATIENTS AND METHODS: We present a retrospective, descriptive, single-center study of 37 children with a confirmed diagnosis of AADC deficiency. Their medical histories were reviewed for motor milestones, motor development, DDC mutation, and body weight. The termination point for each patient in this study was defined as no further follow-up, death, or enrollment in a gene therapy trial. RESULTS: The median age of the study patients at the end of the study was 4.39 years (1.28-11.30). Of the 37 patients, 36 did not develop full head control, sitting ability, standing ability, or speech at any time point from birth to the termination points. Motor scales were administered to 22 patients. Their Alberta Infant Motor Scale scores were below the fifth percentile, and their Peabody Developmental Motor Scales, Second Edition, scores were below the first percentile. Their body weights were normal in the first few months of life, but severe growth retardation occurred at later ages. The mutation c.714+4A>T (IVS6+4A>T) accounted for 76% of all their DDC mutations. CONCLUSION: In this chapter, we report the clinical course of AADC deficiency in Taiwan. Our data will help guide the development of treatment strategies for the disease.
OBJECTIVES:Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare inherited disorder of monoamine neurotransmitter synthesis; this deficiency leads to psychomotor delay, hypotonia, oculogyric crises, dystonia, and extraneurological symptoms. This study aimed to provide further insight into the clinical course of AADC deficiency in Taiwan. PATIENTS AND METHODS: We present a retrospective, descriptive, single-center study of 37 children with a confirmed diagnosis of AADC deficiency. Their medical histories were reviewed for motor milestones, motor development, DDC mutation, and body weight. The termination point for each patient in this study was defined as no further follow-up, death, or enrollment in a gene therapy trial. RESULTS: The median age of the study patients at the end of the study was 4.39 years (1.28-11.30). Of the 37 patients, 36 did not develop full head control, sitting ability, standing ability, or speech at any time point from birth to the termination points. Motor scales were administered to 22 patients. Their Alberta Infant Motor Scale scores were below the fifth percentile, and their Peabody Developmental Motor Scales, Second Edition, scores were below the first percentile. Their body weights were normal in the first few months of life, but severe growth retardation occurred at later ages. The mutation c.714+4A>T (IVS6+4A>T) accounted for 76% of all their DDC mutations. CONCLUSION: In this chapter, we report the clinical course of AADC deficiency in Taiwan. Our data will help guide the development of treatment strategies for the disease.
Authors: Claudio Graziano; Anita Wischmeijer; Tommaso Pippucci; Carlo Fusco; Chiara Diquigiovanni; Margit Nõukas; Martin Sauk; Ants Kurg; Francesca Rivieri; Nenad Blau; Georg F Hoffmann; Alka Chaubey; Charles E Schwartz; Giovanni Romeo; Elena Bonora; Livia Garavelli; Marco Seri Journal: Gene Date: 2015-01-14 Impact factor: 3.688
Authors: M A Spitz; M A Nguyen; S Roche; B Heron; M Milh; P de Lonlay; L Lion-François; H Testard; S Napuri; M Barth; S Fournier-Favre; L Christa; C Vianey-Saban; C Corne; A Roubertie Journal: JIMD Rep Date: 2016-05-05
Authors: Johanna Darrah; Doreen Bartlett; Thomas O Maguire; William R Avison; Thierry Lacaze-Masmonteil Journal: Dev Med Child Neurol Date: 2014-03-29 Impact factor: 5.449
Authors: Tessa Wassenberg; Marta Molero-Luis; Kathrin Jeltsch; Georg F Hoffmann; Birgit Assmann; Nenad Blau; Angeles Garcia-Cazorla; Rafael Artuch; Roser Pons; Toni S Pearson; Vincenco Leuzzi; Mario Mastrangelo; Phillip L Pearl; Wang Tso Lee; Manju A Kurian; Simon Heales; Lisa Flint; Marcel Verbeek; Michèl Willemsen; Thomas Opladen Journal: Orphanet J Rare Dis Date: 2017-01-18 Impact factor: 4.123
Authors: Toni S Pearson; Laura Gilbert; Thomas Opladen; Angeles Garcia-Cazorla; Mario Mastrangelo; Vincenzo Leuzzi; Stacy K H Tay; Jolanta Sykut-Cegielska; Roser Pons; Saadet Mercimek-Andrews; Mitsuhiro Kato; Thomas Lücke; Mari Oppebøen; Manju A Kurian; Dora Steel; Filippo Manti; Kathleen D Meeks; Kathrin Jeltsch; Lisa Flint Journal: J Inherit Metab Dis Date: 2020-05-14 Impact factor: 4.982
Authors: Jerry R Mendell; Samiah A Al-Zaidy; Louise R Rodino-Klapac; Kimberly Goodspeed; Steven J Gray; Christine N Kay; Sanford L Boye; Shannon E Boye; Lindsey A George; Stephanie Salabarria; Manuela Corti; Barry J Byrne; Jacques P Tremblay Journal: Mol Ther Date: 2020-12-10 Impact factor: 11.454